[1]杜秋越,刘易欣,陈 凌.免疫组化指标在宫颈微偏腺癌诊断中的应用[J].医学信息,2018,31(09):53-55.[doi:10.3969/j.issn.1006-1959.2018.09.017]
　DU Qiu-yue,LIU Yi-xin,CHEN Ling.Application of Immunohistochemical Markers in Diagnosis of Minimal Deviationadenocarcinoma of Cervix[J].Journal of Medical Information,2018,31(09):53-55.[doi:10.3969/j.issn.1006-1959.2018.09.017]
点击复制

免疫组化指标在宫颈微偏腺癌诊断中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年09期
页码:
53-55
栏目:
综述
出版日期:
2018-05-01

文章信息/Info

Title:
Application of Immunohistochemical Markers in Diagnosis of Minimal Deviationadenocarcinoma of Cervix
文章编号:
1006-1959（2018）09-0053-03
作者:
杜秋越; 刘易欣; 陈 凌
天津市中心妇产科医院病理科，天津 300100
Author(s):
DU Qiu-yue; LIU Yi-xin; CHEN Ling
Department of Pathology,Tianjin Central Obstetrics and Gynecology Hospital,Tianjin 300100,China
关键词:
宫颈; 微偏腺癌; 免疫组化; HIK1083
Keywords:
Key words：Cervixis; Minimal deviationadenocarcinoma; Immunohistochemistry;  HIK1083
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2018.09.017
文献标志码:
A
摘要:
宫颈微偏腺癌（MDA)是一种原发于宫颈的特殊类型腺癌，发病率较低。虽然肿瘤细胞分化很好，但是该种肿瘤患者预后极差。由于缺乏恶性细胞学特征，细胞学检查（TCT）几乎无法做出诊断；且由于活检组织标本较小、腺体形态及结构均类似于正常宫颈腺体，活检病理检查也极易漏诊。近年来多项免疫组化指标的联合应用有助于对MDA做出正确的病理诊断，本文对这些免疫组化指标在宫颈微偏腺癌中的应用进行了归纳总结。
Abstract:
Abstract：Minimal deviationadenocarcinoma of cervixis(MDA)a type of adenocarcinoma of primary origin in the cervix with a low incidence.Although tumor cells differentiate well,the prognosis of this tumor patient is extremely poor.Due to the lack of malignant cytological features,cytology tests(TCT)can hardly make a diagnosis;and because biopsy tissue specimens are small,glandular morphology and structure are similar to normal cervical glands,biopsy pathological examination is also easily missed.In recent years, the combined use of multiple immunohistochemical markers has contributed to the correct pathological diagnosis of MDA.The application of these immunohistochemical markers in cervical minimal deviation adenocarcinoma is summarized in this paper.

参考文献/References:

[1]李亚玲.宫颈微偏腺的诊疗现状[D].河北:河北医科大学,2017.
[2]Takahiro T,Shinichi T,Mitsuharu N,et al.Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia[J].Histopathology,2011,59(1):55-62.
[3]伊喜苓,林蓓,朱连成,等.269例子宫颈微偏腺癌的meta分析[J].中国医科大学学报,2009,38(5):369-372.
[4]郑文新,沈丹华.妇产科病理学[M].北京:科学出版社,2013.
[5]王炜晨,羊正炎.宫颈微偏腺癌201例分析[J].现代实用医学,2012,24(3):321-322.
[6]栾贺.中国宫颈微偏腺癌临床及病理特征的Meta分析[D].大连医科大学,2014.
[7]伊喜苓,朱连成,林蓓,等.宫颈微偏腺癌25例临床病理分析[J].现状肿瘤医学,2014,22(1):157-160.
[8]翁亚菡,赵海洋,梁瑞敏,等.免疫组化在宫颈微偏腺癌临床诊断中的作用分析[J].现代诊断与治疗,2014,5(20):4773-4775.
[9]田 芳,周庆云,王玥元,等.宫颈微偏腺癌4例报道[J].诊断病理学杂志,2015,22(8):507-509.
[10]Li G,Zhang WD,Liu XY,et al.Clonal status and clinicopathological observation of cervical minimal deviation adenocarcinoma[J].Diagn Pathol,2010,5(1):25.
[11]李旻,曹箭,王乃鹏.等.P16INK4a免疫细胞化学检测在筛查宫颈癌中的作用[J].中华肿瘤杂志,2006,28(9):674-677.
[12]刘潇阳,李青,陈汶,等.宫颈管型腺癌的人乳头瘤病毒感染及P16和孕激素受体的染色特征[J].中华肿瘤杂志,2014,36(4):263-267.
[13]Poi MJ,Knobloch TJ,Yuan C,et al.Evidence that P12,a specific variant of P16(INK4A),plays a suppressive role in human pancrestic carcinogenesis[J].Biochem Biophys ResCommun,2013,436(2):217-222.
[14]Rojas IQ.The cervical cancer prevention programme in Costa Rica[J].Ecancer medical science,2015,9(82):578.
[15]Lin CQ,Cui JF,Zhang X,et al.Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China[J].Acta cytological,2015,59(5):405-411.
[16]刘彬,吴泽妮,刘潇阳,等.人乳头瘤病毒与子宫颈腺癌病因关系研究[J].中华肿瘤杂志,2016,38(4):277-282.
[17]刘海燕.Ki-67、MUC2、MUC6蛋白在宫颈微偏腺癌中的表达及意义[D].南华大学,2016.
[18]朱连成,伊喜苓,林蓓,等.p53、Ki67和CA125表达在宫颈微偏腺癌与普通宫颈腺癌鉴别中的价值[J].现代肿瘤医学,2015,23(16):2368-2371.
[19]Macha MA,Krishn SR,Jahan R,et al.Emerging potential of natural products for targeting mucins for therapy against inflammation and cancer[J].Cancer Treat Rev,2015,41(3):277-288.
[20]张典,高兴春,姜凤良,等.黏蛋白在肿瘤诊断和治疗中的作用[J].中国老年学杂志,2016,36(9):2275-2277.
[21]秦玲,宋洪涛,耿敬姝,等.粘蛋白在宫颈腺体病变的表达及意义[J].现代生物医学进展,2014,33(4):6502-6505.
[22]李彦敏,周奕琳,郭雪西,等.粗针活检诊断子宫颈微偏腺癌4例及临床病理分析[J].临床与实验病理学杂志,2011,27(6):623-626.
[23]翁亚菡,赵海洋,梁瑞敏,等.免疫组化在宫颈微偏腺癌临床诊断中的作用分析[J].现代诊断与治疗,2014,25(20):4773-4775.
[24]罗茹,陈晓端,朱莉艳.宫颈高级别腺上皮内瘤变80例临床病理及免疫组织化学观察[J].中华病理学杂志,2013,42(1):32-36.
[25]Glenn Mc Cluggage W.Immunohistochemistry as a diagnostic aid in cervical pathology[J].Pathology,2007,39(1):97-111.

相似文献/References:

[1]李成诚,李 珣,李 明,等.宫颈HPV感染治疗现状[J].医学信息,2018,31(19):40.[doi:10.3969/j.issn.1006-1959.2018.19.014]
　LI Cheng-cheng,LI Xun,LI Ming,et al.Current Status of Treatment of Cervical HPV Infection[J].Journal of Medical Information,2018,31(09):40.[doi:10.3969/j.issn.1006-1959.2018.19.014]

更新日期/Last Update: 2018-05-01